ライフサイエンスコーパス: grade

1 thritis features (Kellgren and Lawrence [KL] grade).

2 dard clinical techniques (LFP, clinical cell grading).

3 clinical practice outcomes (OSCE and mentor grading).

4 and 417 students were reassessed in the 11th grade.

5 clonal expansion and recurrence at a higher grade.

6 rease occurred across all sites, stages, and grades.

7 nd elevated ANXA2 levels in increasing tumor grades.

8 ercentage of CNP-pixels and also with manual grading.

9 At baseline, 34% of subjects had steatosis grade 0 or 1, 39% had steatosis grade 2, and 27% had ste

10 ignificant difference between grade >/=3 and grade 0 patients (P = 0.02).

11 (sensitivity 82%) and 9 of 14 patients with grade 0 toxicity (specificity 64%).

12 Results Low-grade tumors (grade 0, 1, or 2) demonstrated a favorable long-term tre

13 e PfSPZ Vaccine and placebo groups, and only grade 1 (mild) local or systemic adverse events occurred

14 apeutic anticoagulation is not necessary for grade 1 and 2 arterial and grade 1 venous thrombosis.

15 In grade 1 HE the S-ANT1 was lower than in MHE.

16 isorientation or asterixis (minimal HE [MHE]/grade 1 HE) is important.

17 with grade 3 fibrosis than in patients with grade 1 or 2 fibrosis.

18 atment-related adverse events were generally grade 1 or 2 in severity.

19 e (72%); however, the majority of these were grade 1 or 2.

20 se in patients with RLI grade 2 or higher vs grade 1 or lower (RFS at 3 years, 6.4% [3 of 50] vs 39.2

21 not necessary for grade 1 and 2 arterial and grade 1 venous thrombosis.

22 ecipients were diagnosed with PAT (including grade 1).

23 nfirmed, previously untreated, CD20-positive grade 1, 2, or 3a follicular lymphoma; Eastern Co-operat

24 Seven men had Clavien-Dindo grade 1-2 complications.

25 Common grade 1-2 toxicities included upper respiratory tract in

26 erienced drug-related adverse events (mostly grade 1-2); none discontinued treatment due to adverse e

27 For all early AMD (grade 1-3), there was no relationship with MDS (P trend

28 r unifocal invasive ductal adenocarcinoma of grade 1-3, with a tumour size of 3 cm or less (pT1-2), n

29 The cumulative burden of grade 1-5 CHCs at age 50 years was highest in survivors

30 ssociated reactions (IARs) (56%), which were grade 1/2 in 84% of patients who had an IAR and predomin

31 verse event (AE); the majority of these were grades 1 and 2, with 26% of patients experiencing a grad

32 ts (AEs) occurred in 98% of patients, mostly grades 1 and 2.

33 ities attributable to study drug, which were grade 2 neurocognitive adverse events comprising slowed

34 palpable spleen of at least 5 cm and without grade 2 or greater peripheral neuropathy were included i

35 in situ (cervical intraepithelial neoplasia grade 2 or higher [CIN2+]) in 2008.

36 ic resection were worse in patients with RLI grade 2 or higher vs grade 1 or lower (RFS at 3 years, 6

37 The primary endpoint was incidence of grade 2 or worse stomatitis by 8 weeks assessed in the f

38 By 8 weeks, the incidence of grade 2 or worse stomatitis was two (2%) of 85 patients

39 Acute grade 2 pneumonitis occurred in 1 (2%) patient.

40 Adverse events were generally mild (</= grade 2), with diarrhea (44%), blurred vision (41%), nau

41 ad steatosis grade 0 or 1, 39% had steatosis grade 2, and 27% had steatosis grade 3; corresponding me

42 rgan failure (acute-on-chronic liver failure grade 2-3).

43 iple phenotype of MBC was luminal A, ductal, grade 2.

44 orting of cervical intraepithelial neoplasia grades 2/3 and adenocarcinoma in situ (cervical intraepi

45 osed with cervical intraepithelial neoplasia grade 3 (CIN3).

46 26 (39%) of 44 patients had grade 3 adverse events, but no grade 4 events were repor

47 1 and 2, with 26% of patients experiencing a grade 3 AE.

48 The most frequently observed grade 3 and 4 adverse events were transaminase increases

49 Fewer grade 3 and 4 treatment-related adverse events were obse

50 Other grade 3 disorders included hepatobiliary and renal disor

51 these areas was much lower in patients with grade 3 fibrosis than in patients with grade 1 or 2 fibr

52 myositis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocar

53 No grade 3 or 4 adverse events were reported in either stud

54 Fifty-five percent of patients had grade 3 or 4 neurologic toxicities that completely resol

55 [DP], 13%) versus 33% of high-grade tumors (grade 3 or 4) (complete response, 0%; partial response,

56 The roots with radicular grooves (grade 3 or 4) were defined as Tome's anomalous root and

57 The most common adverse events of grade 3 or higher during treatment were neutropenia (in

58 Adverse events of grade 3 or higher were reported in 87% of the patients i

59 control group, the most frequently reported grade 3 or worse adverse events were diarrhoea (103 [21%

60 The most common adverse events of grade 3 or worse severity were anaemia (38 [19%] of 195

61 Common grade 3 or worse toxic effects were related to the lymph

62 Grade 3 or worse treatment-related adverse events occurr

63 3 thrombocytopenia, anaemia, or bleeding at grade 3 or worse, with palpable spleen of at least 5 cm

64 n to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis).

65 IMRT was associated with less >/= grade 3 pneumonitis (7.9% v 3.5%, P = .039) and a reduce

66 than 20 mg twice a day with at least one of grade 3 thrombocytopenia, anaemia, or bleeding at grade

67 ated adverse events (myositis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumoni

68 Fifteen patients experienced grade 3 to 4 adverse events; the most common were fluid

69 elinexor at 35 or 60 mg/m(2) The most common grade 3 to 4 drug-related adverse events were thrombocyt

70 ly skin related, GI, endocrine, and hepatic; grade 3 to 4 select AEs occurred in 4% of patients.

71 Grade 3 to 4 treatment-related adverse events were repor

72 median follow-up of 32 months, there were no grade 3 toxicities.

73 patient experienced a dose-limiting toxicity-grade 3 transient asymptomatic hyponatremia at the 1.0-m

74 Five (15%) patients had 11 grade 3 treatment-related adverse events; no single even

75 trastuzumab emtansine plus pertuzumab had a grade 3-4 adverse event (29 [13%] of 223 vs 141 [64%] of

76 %] of 378 patients in the control group) and grade 3-4 adverse events (52 [7%] patients vs 31 [8%] pa

77 Rates of grade 3-4 adverse events did not differ among regimens (

78 The most common grade 3-4 adverse events were decreased neutrophil count

79 The most comment grade 3-4 adverse events were neutropenia (n=2 [5%]), hy

80 The most common grade 3-4 adverse events with a suspected association wi

81 Grade 3-4 cytokine release syndrome occurred in 46% of p

82 The most common grade 3-4 haematological adverse events reported, irresp

83 The association with grade 4 or grade 3-4 health conditions was highly significant for a

84 Radioimmunotherapy toxicity consisted of grade 3-4 thrombocytopenia in 48 (84%) of 57 patients an

85 During enzalutamide retreatment, no grade 3-4 toxicities occurred in more than one patient.

86 y grade, of which 4.7 (4.6-4.9) were CHCs of grade 3-5.

87 albumin, bilirubin, and alkaline phosphatase grade 3/4 toxicities were, respectively, 3%, 10%, and 0%

88 had steatosis grade 2, and 27% had steatosis grade 3; corresponding mean PDFF values were 9.8%+/-3.7%

89 patients had grade 3 adverse events, but no grade 4 events were reported.

90 s, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis).

91 Grade 4 non-haematological toxicity was uncommon; as exp

92 No grade 4 or 5 AEs were observed.

93 The association with grade 4 or grade 3-4 health conditions was highly signif

94 Grade 4 toxicity occurred in 32%, and 5% had treatment-a

95 Of the 88 deaths (grade 5 adverse events) reported during the study (50 pa

96 There were no acute or late grade 5 toxic effects.

97 (per 100-g increase in birth weight, -0.004 grade, 95% CI: -0.04, 0.04) using instrumental variable

98 ve a small positive association (0.02 higher grade, 95% CI: 0.01, 0.03).

99 High-quality (grade A) TR Doppler was present in 68% at rest and 34% a

100 d on the basis of adverse events, which were graded according to the Common Terminology Criteria for

101 System (IPSS-R) and presence of comorbidity graded according to the HCT Comorbidity Index (HCT-CI) w

102 us photographs were obtained of each eye and graded according to the modified Airlie House classifica

103 Recommendations were graded according to the strength of underlying evidence

104 troscopy, conventionally adopted for quality grading according to the ISO Normative 3632.

105 ced hyperglycemia among the most common high grade adverse events.

106 ly data-driven artificial intelligence-based grading algorithm can be used to screen fundus photograp

107 e them cost-effective alternatives to manual grading alone.

108 a new candidate susceptibility gene for low-grade and borderline serous EOC.

109 timal rCBV ratio to distinguish between high-grade and low-grade glial tumors.

110 ly correlated with cell proliferation, tumor grade and malignancy.

111 s also have predictive value regarding tumor grade and patient outcomes.

112 =0.021 and P=0.05, respectively), whereas CE grade and the presence of neovessels were not.

113 study investigated the effectiveness of ITSS grading and rCBV ratio in preoperative assessment.

114 ith nivolumab monotherapy were primarily low grade, and most resolved with established safety guideli

115 k by tumor characteristics (i.e., histology, grade, and stage).

116 Although the existing classification and grading approach is of prognostic value, it harbours sho

117 ne of seronegative individuals in a research-grade assay.

118 There was a graded association also in the cosibling design comparin

119 A steep-graded association exists between decreasing number of c

120 test was used to compare the distribution of grades at each station between conventional MR lymphangi

121 gh-grade glioma (AUC, 0.854) and for all WHO grades (AUC, 0.899) among all biomarkers.

122 ernational Study Group on Pancreatic Fistula Grade B or C) and hospital-related inpatient costs for 9

123 llicular lymphoma, and MYC/BCL2/BCL6 in high-grade B-cell lymphomas are essential for diagnosis.

124 ssachusetts, were enrolled in the 8th or 9th grade (baseline; mean [SD] age, 14.4 [0.7] years).

125 The images were graded by 2 retinal physicians and average measurements

126 us, and superficial middle cerebral vein was graded by one neuroradiologist, as follows: 0, not visib

127 Operators subjectively graded calcifications as hard, soft, or fluid according

128 g (31 mutations per sample +/- 15), and high-grade cancer (33 mutations per sample +/- 18) (P = .30).

129 -and 97 healthy controls performed a maximal graded cardiopulmonary exercise test with continuous mea

130 observed in patients with asymptomatic high-grade carotid disease versus patients with acutely sympt

131 ict occurrence of residual or recurrent high-grade cervical intraepithelial neoplasia of grade two or

132 r-protocol population, the incidence of high-grade cervical, vulvar and vaginal disease related to HP

133 croRNA profiles, immunosenescence, and a low-grade chronic inflammation (inflammaging).

134 Osteoarthritis (OA) is a low-grade chronic inflammatory joint disease.

135 Low-grade, chronic inflammation has been associated with man

136 esent and carefully characterize an industry-grade CMOS camera as a cost-efficient alternative to com

137 Graded concentrations of xDP, xFP, and waDP were adminis

138 uman with tetraplegia can regain volitional, graded control of muscle contraction in his paralyzed li

139 h as ill-defined parameters for subtypes and grading criteria prone to arbitrary judgment.

140 evaluated, with two evaluators independently grading CVR and SOR.

141 cal incisions, sutures, and corrections were graded during and immediately after surgery.

142 erson-years among patients with baseline low-grade dysplasia (95% CI 1.5-7.2), and 7.3 per 100 person

143 rson-years among patients with baseline high-grade dysplasia (95% CI 4.2-12.5).

144 Barrett's esophagus for progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC

145 factors associated with progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC)

146 -27), whereas the probability of having high-grade dysplasia or intramucosal adenocarcinoma was 87% (

147 r LGD, and 0.43 (95% CI, 0.36-0.46) for high-grade dysplasia.

148 ostate stem-cell antigen could identify high-grade dysplasia/cancer with an accuracy of 96% (95% CI,

149 Two trained non-physician readers graded each eye independently for ROP features in a 5 re

150 The proposed mechanism accounts for the graded emergence of gamma oscillations at the stimulatio

151 modulation in earlier studies that used high-grade equipment in laboratory settings.

152 We aimed to test the efficacy and safety of graded exercise delivered as guided self-help.

153 ohort, established in 1986-1987, underwent a graded exercise test of aerobic fitness to measure maxim

154 In Drosophila, graded expression of the maternal transcription factor B

155 lutamatergic pathway activating the MLR in a graded fashion, and consequently evoking a progressive i

156 soft-tissue sarcoma, of intermediate or high grade, for which no standard curative therapy was availa

157 of 253902 students in eighth, 10th, and 12th grades from 2010 to 2015 from Monitoring the Future, a n

158 d with prognostic factors such as histologic grade (G1, G2, or G3, for low-grade [well differentiated

159 io to distinguish between high-grade and low-grade glial tumors.

160 mance for IDH gene mutation detection in low-grade glioma (AUC, 0.818) and MTI in high-grade glioma (

161 ow-grade glioma (AUC, 0.818) and MTI in high-grade glioma (AUC, 0.854) and for all WHO grades (AUC, 0

162 ealth Organization [WHO] grade II) from high-grade glioma (HGG) (WHO grade III or IV).

163 kurtosis imaging (DKI) to differentiate low-grade glioma (LGG) (World Health Organization [WHO] grad

164 ons observed during the development of lower-grade glioma (LGG).

165 lticenter trial involving patients with high-grade glioma.

166 with significantly inferior survival in low-grade glioma.

167 High-grade gliomas (HGGs) include the most common and the mos

168 These pediatric low-grade gliomas (LGGs) are fundamentally different from ID

169 Infiltrating low grade gliomas (LGGs) are heterogeneous in their behavior

170 n IDH1 have been implicated in >80% of lower grade gliomas and secondary glioblastomas and primarily

171 found in the majority of patients with lower grade gliomas.

172 cally-annotated and genetically-defined high grade gliomas.

173 line grades the recommendations by using the GRADE (Grading of Recommendations Assessment, Developmen

174 s the evidence and recommendations using the GRADE (Grading of Recommendations Assessment, Developmen

175 he ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Developmen

176 en formulated, written, and graded using the GRADE (Grading of Recommendations, Assessment, Developme

177 r VOIs were marked as high-grade (>/=Gleason grade group 3) or not.

178 Incidence of grade >/= 3 AEs was 45% and 35%, respectively.

179 P = .01) were significantly associated with grade >/= 3 cardiac events.

180 to find cervical intraepithelial neoplasia (grade >/=2 [CIN2+] or grade >/=3 [CIN3+]).

181 aepithelial neoplasia (grade >/=2 [CIN2+] or grade >/=3 [CIN3+]).

182 Grade >/=3 adverse events (AEs; >5%) included anemia, pn

183 grade, with a significant difference between grade >/=3 and grade 0 patients (P = 0.02).

184 lisib group compared with the placebo group (grade >/=3 infections and infestations: 80 [39%] of 207

185 correctly classified 23 of 28 patients with grade >/=3 toxicity (sensitivity 82%) and 9 of 14 patien

186 %; P = .21), severe complications (Accordion grade >/=3, 23.05% vs 23.7%; P > .99), hospital stay (me

187 Tumor VOIs were marked as high-grade (>/=Gleason grade group 3) or not.

188 patient age, year of diagnosis, tumor size, grade, hormone receptors, and ERBB2/HER2 and Ki67 status

189 with an increased risk for low-intermediate grade (HR, 1.14; 95% CI, 1.01 to 1.29) but not high-grad

190 Novel food-grade hybrid encapsulation structures based on the entra

191 s benign, slow-growing lesions classified as grade I or II by the WHO classification of CNS tumors.

192 cancers we identified ZEB1 deletion in 15% (grade II and III) and 50% of glioblastomas.

193 lass II or III furcation involvements and/or Grade II or III tooth mobility were also detected in the

194 Grade II to IV acute graft-versus-host disease related t

195 lioma (LGG) (World Health Organization [WHO] grade II) from high-grade glioma (HGG) (WHO grade III or

196 Results Low-grade (WHO grade II) glioma showed areas with increased OEF (+18%,

197 grade II) from high-grade glioma (HGG) (WHO grade III or IV).

198 Acute GVHD, either grade III to IV (30 patients, 33%) or refractory (12 pat

199 001, n = 20), whereas anaplastic glioma (WHO grade III) and glioblastoma (WHO grade IV) showed decrea

200 n, and 26.9% experienced major morbidity (>/=grade III), mostly related to pulmonary complications (2

201 c vascular territories was associated with a graded increase in the 3-year rates of VTE (0.76% for 1,

202 es are associated with increased chronic low-grade inflammation and elevated plasma glucose levels.

203 lenge the common assumption that central low-grade inflammation in schizophrenia is mirrored by incre

204 Thus, microglia and low-grade inflammation of myelinated tracts emerged as the t

205 Chronic low-grade inflammation, a hallmark of obesity, involves immu

206 s neoplasms (IPMN), 2 adenocarcinomas, 1 low-grade intraepithelial pancreatic neoplasia, and 1 case o

207 mits the growth of intractable glioblastoma (grade IV glioma) and glioma stem cells (GSCs).

208 glioma (WHO grade III) and glioblastoma (WHO grade IV) showed decreased OEF when compared with normal

209 The types of defective materials regarded in grading legislation were divided into 13 classes, and we

210 cases of high-risk (hr) HPV-associated high-grade lesions and carcinomas in the anogenital region an

211 of electromagnetic and acoustic waves using graded metasurfaces.

212 ow-grade [well differentiated], intermediate-grade [moderately differentiated], and high-grade [poorl

213 ture range through design of compositionally graded multilayer (CGML) architecture.

214 ts included safety, assessed as the rate and grade of adverse events.

215 omply with both principles since their first grade of primary school.

216 s with AMPK activity in glioma specimens and grades of glioma malignancy.

217 ncreased key BAs were associated with higher grades of steatosis (taurocholate), lobular (glycocholat

218 coronary anatomy and for early detection and grading of coronary lesions in non-diabetic patients.

219 Concordance between external and internal grading of external studies was improved when diagnostic

220 Glaucoma was diagnosed based on a masked grading of optic disc stereophotographs.

221 The Grading of Recommendation Assessment, Development and Ev

222 ades the recommendations by using the GRADE (Grading of Recommendations Assessment, Development and E

223 grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and E

224 ut initial treatment approaches by using the Grading of Recommendations Assessment, Development and E

225 vidence and recommendations using the GRADE (Grading of Recommendations Assessment, Development, and

226 According to the Grading of Recommendations Assessment, Development, and

227 ulated, written, and graded using the GRADE (Grading of Recommendations, Assessment, Development, and

228 ce (i.e., the quality of evidence) using the Grading of Recommendations, Assessment, Development, and

229 PDFF, but not CAP, enabled the grading of steatosis (P < .0001).

230 is surpassed), e-ROP IMAGING (trained reader grading of type 1 or 2 ROP initiates diagnostic examinat

231 Grading of written descriptions for observational and de

232 average, 17.1 (95% CI 16.2-18.1) CHCs of any grade, of which 4.7 (4.6-4.9) were CHCs of grade 3-5.

233 mising for the detection of lower processing grade oils in EVOO.

234 ncentrations of the three compounds in lower grade olive oils were significantly higher (P<.001) than

235 Each patient year was graded on the The International League against Epilepsy

236 hey are, however, less likely to have higher grade or multivessel CAD.

237 ial Organ Failure Assessment (SOFA) score to grade organ dysfunction in adult patients with suspected

238 was some evidence of heterogeneity by tumor grade ( P = .02), with an increased risk for low-interme

239 stage (P < 0.001), N stage (P < 0.001), and grade (P = 0.049).

240 lls on OCT increased among all cell clinical grades (P < 0.0001).

241 derived SUVs were observed between different grades (P = 0.38).

242 tween NRP1 expression and increasing Gleason grade, pathological T score, positive lymph node status

243 al associated with the process of converting graded perceptual signals into a categorical format unde

244 g chlorogenic and rosmarinic acids, and food-grade phenolic apple and rosemary extracts at various do

245 -grade [moderately differentiated], and high-grade [poorly differentiated], respectively), chromogran

246 steoarthritis Research Society International grading (progression in 1st-, 2nd-, 3rd-, 4th-, 6th-, or

247 Treatment-related adverse events (any grade) prompted treatment discontinuation in four (11%)

248 HR, 1.14; 95% CI, 1.01 to 1.29) but not high-grade prostate cancer (HR, 0.83; 95% CI, 0.64 to 1.07).

249 interpretation of results, and a system for grading quality of test efforts.

250 sability were assessed with the chronic pain grade questionnaire.

251 to optimal field and transformation to high-grade radiation-associated sarcomas.

252 Correlations between SWI grade, rCBV ratio, and pathological grading were evaluat

253 samples (n = 158) were tested with research-grade reagents and 122 independent validation set sample

254 eliberation, the ECDP writing committee down-graded recommendations regarding bile acid sequestrant u

255 num-based chemotherapy in patients with high-grade, recurrent, platinum-sensitive ovarian carcinoma.

256 s developed as a simple clinical and imaging grading scale for acute prognosis in patients with PICH.

257 Transplantable murine models of ovarian high grade serous carcinoma (HGSC) remain an important resear

258 ars or older, had a platinum-sensitive, high-grade serous or endometrioid ovarian, primary peritoneal

259 gh) groups, especially in patients with high-grade serous ovarian cancer (HGSOC).

260 no approved biomarkers for olaparib in high-grade serous ovarian cancer (HGSOC).

261 resistance in ovarian and other cancers.High-grade serous ovarian cancers (HGS-OvCa) frequently devel

262 he lack of effective chemotherapies for high-grade serous ovarian cancers (HGS-OvCa) has motivated a

263 iation, we found hematopoietic phenotypes of graded severity and/or stage specificity that together d

264 Graded shocks to the solitary tract (ST) always (93%) tr

265 apid vortex agitation (>/=3200 rpm) in LC/MS-grade solvents and by exposing them to the DART source j

266 tudy included 90 comatose patients with high-grade spontaneous subarachnoid hemorrhage who underwent

267 of undetermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were t

268 this proportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (

269 carcinoid syndrome (p<0.0001), as was tumour grade, stage, and primary tumour site (all p<0.0001).

270 (Grade: strong recommendation; moderate-quality evidence)

271 Using the ACP grading system, the committee based these recommendation

272 vidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of

273 tographs were graded using the Wisconsin AMD grading system.

274 rity criteria, lack of consistent scoring or grading systems for primary and safety outcomes, and lac

275 Here we evaluated performance of a novel, graded test for objectively detecting inattention in del

276 ation Taxonomy (SORT) method to evaluate and grade the quality of evidence.

277 extracted data, assessed study quality, and graded the strength of the evidence.

278 This guideline grades the evidence and recommendations by using the ACP

279 This guideline grades the evidence and recommendations using the GRADE

280 This guideline grades the recommendations by using the GRADE (Grading o

281 .001, I2 = 85%); when SMR was qualitatively graded, the incidence of all-cause mortality was signifi

282 old stress following the administration of a graded thermal stimuli delivered to the stomach via flui

283 r, although it resulted in more frequent low-grade toxicities.

284 lytic gradient is established in response to graded transcription of glycolytic enzymes downstream of

285 The island rule describes a graded trend in insular populations of vertebrates from

286 Results Low-grade tumors (grade 0, 1, or 2) demonstrated a favorable

287 se progression [DP], 13%) versus 33% of high-grade tumors (grade 3 or 4) (complete response, 0%; part

288 rfusion and metabolism between low- and high-grade tumors in the transgenic adenocarcinoma of mouse p

289 -grade cervical intraepithelial neoplasia of grade two or worse (CIN2+) and compared it with post-tre

290 endations were then formulated, written, and graded using the GRADE (Grading of Recommendations, Asse

291 Fundus photographs were graded using the Wisconsin AMD grading system.

292 acy for categorization by Genant height loss grade was 0.68 (77 of 113; 95% CI: 0.59, 0.76), with a w

293 nterreader agreement on venous contamination grades was assessed by using the linearly weighted Cohen

294 as histologic grade (G1, G2, or G3, for low-grade [well differentiated], intermediate-grade [moderat

295 at time of reaction and anaphylaxis severity grades were retrieved.

296 ween SWI grade, rCBV ratio, and pathological grading were evaluated.

297 Results Low-grade (WHO grade II) glioma showed areas with increased

298 uring Visit 1, 356 (39.3%) participants were graded with a normal image.

299 imple spikes are reduced in a manner that is graded with spikelet number.

300 ay ratio correlated negatively with toxicity grade, with a significant difference between grade >/=3